Val built the non-technical market access capability of a large International Pharma business from scratch. She coached brand and sales teams to better understand the functions of market access and integrated the work into strategic planning, mapping therapy environments and influencing markets. For example, she introduced an internal market access governance process to align all parts of the business and deliver results in key accounts like NICE, SMC, NPC and DH.
Val has left a strong legacy: a team capable of driving proactive, innovative and focused activity that has tangible effect on the environment. One instance is the work of her team in persuading the Scottish Assembly of the need for better access to VTE prophylaxis. Their work on the Payment by Performance initiative meant VTE prophylaxis was included as a national best tariff in HRG4.
One of Val's clients within the business said: "Val is a rare talent that combines both strategic and in-depth knowledge of the NHS and Private Sectors. She has the business acumen to translate that knowledge into a commercial vision. From that vision, Val is able to passionately influence both immediate and wider teams to produce an actionable plan that drives market access in the short and long term, delivering tangible business results."
The Head of Strategic Accounts who engaged her said: “She is able to passionately influence both immediate and wider teams into an actionable plan, driving market access initiatives in both the short and long term to deliver tangible results and organisational change. With Val’s unique NHS and Commercial background she has the credibility to influence industry senior managers, senior NHS professionals as well as governmental bodies."
